Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$952,180,243
-$65,608,474 QoQ
Shares Held
5,021,518
-2.7% QoQ
Ownership
0.324%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#41
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clearbridge Investments, LLC holds $3,156,802,100 across 12 Drug Manufacturers - General names. AZN ranks #2 (30.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,343,260 | $1,357,027,741 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
5,021,518 | $952,180,243 | |
| 3 | LLY |
ELI LILLY & Co
|
483,528 | $579,958,037 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,088,957 | $137,578,827 | |
| 5 | MRK |
Merck & Co., Inc.
|
565,690 | $72,691,165 | |
| 6 | AMGN |
Amgen Inc
|
69,065 | $25,009,817 | |
| 7 | ABBV |
AbbVie Inc.
|
82,422 | $20,740,672 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
101,597 | $5,854,019 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $952,180,243 | 5,021,518 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,017,788,717 | 5,160,677 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||